Treatment Updates in ADPKD

 

Keck School of Medicine of USC
N

Polycystic Kidney Disease: What Is the Efficacy of Tolvaptan, and How Does It Compare to Other Renal Protective Therapies?

By Keck School of Medicine of USC FEATURING Neera Dahl
By Keck School of Medicine of USC FEATURING Neera Dahl
2,023 views
December 17, 2020
3 Comments
Login to view comments. Click here to Login
Treatment Updates in ADPKD
24:08
KDIGO

ISN-KDIGO Webinar: Genetics of ADPKD Nuances and Complexity

Feat. Y. Pei
35:00
Stanford Medicine

Practical Genetic Testing for the Nephrologist

Feat. A. Aron
38:36
Kidney Nutrition Institute

Practical Application of Ketogenic Diets in PKD

Feat. J. Saville
21:13
University of Colorado Department of Medicine

Targeting Adiposity and Caloric Restriction in ADPKD

Feat. K. Nowak
13:57
Keck School of Medicine of USC

Polycystic Kidney Disease: What Is the Efficacy of Tolvaptan, and Ho…

Feat. N. Dahl
28:31
Fouad Chebib

Current and Emerging Therapies in ADPKD and PLD

40:38
Terry Watnick

PKD Pathobiology: What Do Clinicians Need to Know?

54:55
KDIGO

KDIGO Genetics in CKD Webinar Series Episode 10: Case Studies-How to…

Feat. D. Gale, E. Cornec-Le Gall
27:39
Steven Soroka, Bmus, Md, Msc, Frcpc, Extra Fellow, Che

The Evolution of ADPKD Management in Canada